USANA Health (USJ) Ratios
USANA Health Ratios
DE:USJ's free cash flow for Q2 2026 was $20.16M. For the 2026 fiscal year, DE:USJ's free cash flow was decreased by $-3.15M and operating cash flow was $23.32M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.24 | 2.00 | 3.52 | 2.65 | 2.26 |
| Quick Ratio | 1.45 | 1.50 | 3.00 | 2.18 | 1.65 |
| Cash Ratio | 1.23 | 1.30 | 2.78 | 2.01 | 1.49 |
| Solvency Ratio | 0.32 | 0.40 | 0.62 | 0.56 | 0.76 |
| Operating Cash Flow Ratio | 0.17 | 0.44 | 0.59 | 0.72 | 0.75 |
| Short-Term Operating Cash Flow Coverage | 1.60 | 2.65 | 89.87 | 15.08 | 17.12 |
| Net Current Asset Value | $ 131.76M | $ 117.33M | $ 282.19M | $ 219.15M | $ 180.23M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.05 | 0.02 | 0.02 | 0.03 |
| Debt-to-Equity Ratio | 0.03 | 0.07 | 0.03 | 0.03 | 0.04 |
| Debt-to-Capital Ratio | 0.03 | 0.07 | 0.03 | 0.03 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.39 | 1.41 | 1.27 | 1.37 | 1.46 |
| Debt Service Coverage Ratio | 3.50 | 2.77 | 80.58 | 12.84 | 19.44 |
| Interest Coverage Ratio | 60.41 | 236.03 | 355.23 | 560.49 | 2985.82 |
| Debt to Market Cap | 0.04 | 0.03 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.80 | 2.07 | 0.70 | 0.73 | 0.86 |
| Net Debt to EBITDA | -1.76 | -1.44 | -2.58 | -2.11 | -1.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 78.29% | 79.43% | 79.44% | 79.24% | 80.54% |
| EBIT Margin | 4.58% | 8.97% | 11.15% | 10.90% | 14.39% |
| EBITDA Margin | 8.87% | 11.57% | 13.37% | 13.04% | 16.26% |
| Operating Profit Margin | 5.50% | 7.76% | 10.11% | 10.78% | 14.34% |
| Pretax Profit Margin | 4.49% | 8.94% | 11.12% | 10.88% | 14.38% |
| Net Profit Margin | 1.16% | 4.92% | 6.93% | 6.94% | 9.82% |
| Continuous Operations Profit Margin | 1.24% | 4.92% | 6.93% | 6.94% | 9.82% |
| Net Income Per EBT | 25.91% | 55.05% | 62.26% | 63.85% | 68.27% |
| EBT Per EBIT | 81.65% | 115.12% | 110.08% | 100.94% | 100.26% |
| Return on Assets (ROA) | 1.45% | 5.62% | 10.08% | 11.63% | 20.17% |
| Return on Equity (ROE) | 2.02% | 7.90% | 12.83% | 15.96% | 29.49% |
| Return on Capital Employed (ROCE) | 8.28% | 10.90% | 18.11% | 23.77% | 40.82% |
| Return on Invested Capital (ROIC) | 2.24% | 5.73% | 11.10% | 14.95% | 27.40% |
| Return on Tangible Assets | 2.28% | 9.29% | 10.89% | 12.68% | 22.00% |
| Earnings Yield | 2.98% | 6.18% | 6.18% | 6.77% | 5.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 103.92 | 127.90 | 138.44 | 165.64 |
| Payables Turnover | 11.63 | 14.67 | 18.81 | 18.76 | 17.10 |
| Inventory Turnover | 1.96 | 2.52 | 3.08 | 3.09 | 2.35 |
| Fixed Asset Turnover | 8.30 | 9.04 | 9.23 | 8.48 | 9.45 |
| Asset Turnover | 1.25 | 1.14 | 1.46 | 1.67 | 2.05 |
| Working Capital Turnover Ratio | 6.18 | 3.90 | 3.43 | 4.54 | 5.19 |
| Cash Conversion Cycle | 155.09 | 123.45 | 101.88 | 101.32 | 136.25 |
| Days of Sales Outstanding | 0.00 | 3.51 | 2.85 | 2.64 | 2.20 |
| Days of Inventory Outstanding | 186.47 | 144.83 | 118.43 | 118.14 | 155.40 |
| Days of Payables Outstanding | 31.37 | 24.89 | 19.41 | 19.46 | 21.35 |
| Operating Cycle | 186.47 | 148.34 | 121.29 | 120.77 | 157.60 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.20 | 3.20 | 3.67 | 5.40 | 6.02 |
| Free Cash Flow Per Share | 0.46 | 2.67 | 2.92 | 4.86 | 5.38 |
| Dividend Paid and CapEx Coverage Ratio | 1.62 | 6.05 | 4.87 | 9.99 | 9.50 |
| Capital Expenditure Coverage Ratio | 1.62 | 6.05 | 4.87 | 9.99 | 9.50 |
| Operating Cash Flow Coverage Ratio | 1.60 | 1.56 | 5.35 | 7.54 | 7.01 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.07 | 0.08 | 0.10 | 0.10 |
| Free Cash Flow Yield | 2.36% | 7.48% | 5.44% | 9.13% | 5.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 33.52 | 16.22 | 16.18 | 14.77 | 17.50 |
| Price-to-Sales (P/S) Ratio | 0.39 | 0.80 | 1.12 | 1.03 | 1.72 |
| Price-to-Book (P/B) Ratio | 0.68 | 1.28 | 2.08 | 2.36 | 5.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 42.35 | 13.36 | 18.38 | 10.95 | 18.80 |
| Price-to-Operating Cash Flow Ratio | 16.16 | 11.16 | 14.61 | 9.86 | 16.82 |
| Price-to-Earnings Growth (PEG) Ratio | -0.46 | -0.48 | -2.16 | -0.39 | -9.37 |
| Enterprise Value Multiple | 2.64 | 5.44 | 5.80 | 5.76 | 9.42 |
| Enterprise Value | 216.70M | 537.83M | 714.59M | 749.68M | 1.82B |
| EV to EBITDA | 2.64 | 5.44 | 5.80 | 5.76 | 9.42 |
| EV to Sales | 0.23 | 0.63 | 0.78 | 0.75 | 1.53 |
| EV to Free Cash Flow | 25.42 | 10.56 | 12.73 | 8.02 | 16.75 |
| EV to Operating Cash Flow | 9.70 | 8.82 | 10.12 | 7.22 | 14.98 |
| Tangible Book Value Per Share | 16.97 | 15.23 | 23.39 | 19.98 | 17.22 |
| Shareholders’ Equity Per Share | 28.70 | 27.91 | 25.83 | 22.57 | 19.61 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.72 | 0.45 | 0.38 | 0.36 | 0.32 |
| Revenue Per Share | 49.81 | 44.82 | 47.84 | 51.86 | 58.89 |
| Net Income Per Share | 0.58 | 2.20 | 3.31 | 3.60 | 5.78 |
| Tax Burden | 0.26 | 0.55 | 0.62 | 0.64 | 0.68 |
| Interest Burden | 0.98 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.36 | 0.70 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
| Income Quality | 2.08 | 1.45 | 1.11 | 1.50 | 1.04 |
Currency in USD
